Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome

NCT06697119 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT06697119
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06697119 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome
Lead sponsor
Seoul National University Hospital
Phase
Not applicable
Overall status
Active, not recruiting
Start date
March 9, 2023
Completion date
April 25, 2027
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

irritable bowel disease